<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Cerebrovascular diseases are one of the most important complications of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnostic imaging of neuropsychiatric SLE complications presents many problems </plain></SENT>
<SENT sid="2" pm="."><plain>This study was undertaken to investigate cerebral blood flow char s and its reactivity to <z:mp ids='MP_0002318'>hypercapnia</z:mp> by means of <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> test in SLE patients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Brain SPELT studies using 99mTc-HMPAO were performed in 50 patients with SLE </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="27690">Acetazolamide</z:chebi> test was performed in 35 patients 3 days after the baseline study by means of repetitive scanning 20 min after i.v. injection of 1.0 g of <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Significant interhemispheric hypoperfusion areas were shown in 76.3% of <z:hpo ids='HP_0000001'>all</z:hpo> patients, 83.8% symptomatic and 63.1 % asymptomatic </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> showed multifocal perfusion deficits </plain></SENT>
<SENT sid="7" pm="."><plain>The reaction of cerebral perfusion to <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> was heterogenous and showed increase, decrease, no change or mixed reaction of baseline-study-found focal hypoperfusion </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="27690">Acetazolamide</z:chebi> test revealed hypoperfusion in two patients with <z:mpath ids='MPATH_458'>normal</z:mpath> baseline study </plain></SENT>
<SENT sid="9" pm="."><plain>MRI scanning revealed <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">cerebral lesions</z:e> in 41 % of patients </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: CBF asymmetries in symptomatic and asymptomatic patients with SLE are frequent </plain></SENT>
<SENT sid="11" pm="."><plain>Regional CBF alterations seem to be different in patients with and without <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The part of the patients with SLE shows no or paradoxically inversed reaction to <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> </plain></SENT>
</text></document>